Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice

Highlights from a CME symposium held at the Cardiometabolic Health Congress (CMHC) Sheraton Boston Hotel, Boston, MA, USA, 23 October 2015

Marc S. SabatineThrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital;Department of Medicine, Harvard Medical School, Boston, MACorrespondence[email protected]

James A. UnderbergNYU Medical School, NYU Center for CVD Prevention, Bellevue Hospital Lipid Clinic, New York, NY

Michael KorenJacksonville Center for Clinical Research;Academy of Physicians in Clinical Research, Jacksonville, FL

Seth J. BaumMB Clinical Research;American Society for Preventive Cardiology;The FH Foundation

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice

Highlights from a CME symposium held at the Cardiometabolic Health Congress (CMHC) Sheraton Boston Hotel, Boston, MA, USA, 23 October 2015

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice

Highlights from a CME symposium held at the Cardiometabolic Health Congress (CMHC) Sheraton Boston Hotel, Boston, MA, USA, 23 October 2015

Citations (4)

Articles from other publishers (4)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date